Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients

Pakistan Journal of Pharmaceutical Sciences

Volumn 24, Issue 4, 2011, Pages 565-570

  Ashraf, Rizwan ^a   Khan, Rafeeq Alam ^a   Ashraf, Imran ^b  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Allium sativum; Blood glucose; Diabetes; Garlic

Indexed keywords

CHOLESTEROL; GARLIC EXTRACT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFECT; DRUG EFFICACY; FEMALE; GARLIC; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; FEMALE; GARLIC; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; SINGLE-BLIND METHOD; TRIGLYCERIDES;

EID: 80053460952     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Adler AJ and Holub BJ (1997). Effect of garlic and fresh oil supplementation on serumlipids and lipoproteins concentration in hypercholesterolemic men. Am. J. Clin. Nut., 65: 445-450. (Pubitemid 27130752)
2. Afkhami-Ardekani M, Kamali-Ardekani A and Shojaoddiny-Ardekani A (2006). Effects of garlic on serum lipids and blood glucose of type 2 diabetic patients. Int. J. Diab. Dev. Ctries., 26: 86-88.
3. Ali M and Thomson M (1995). Consumption of garlic clove a day could be beneficial in preventing thrombosis. Prostaglandins Leukot Essent Fatty Acids, 53: 211-212.
4. Al-Qattan K, Thomson M and Ali M (2008). Garlic (Allium sativum) and ginger (Zingiber officinale) attenuate structural nephropathy progression in streptozotocin-induced diabetic rats. Eur E J Clin Nutr Metab, 3: e62-e71.
5. Anwar MM and Meki AR (2003). Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol., 135: 539-547. (Pubitemid 37289114)
6. Ashraf R, Aamir K, Shaikh RA and Ahmed T (2005). Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. J. Ayub. Med. Coll., 17(3): 60-64.
7. Banerjee SK, Mukherjee PK and Maulik SK (2003). Garlic as an antioxidant: The good, the bad and the ugly. Phytother Res., 17: 97-106. (Pubitemid 36262255)
8. Banerjee SK and Maulik SK (2002). Effect of Garlic on cardiovascular disorders; review. Nutr J., 1: 4.
9. Bordia A, Verma SK and Srivastava KC (1998). Effect of garlic (Allium Sativum) on blood lipids, blood sugar, fibrinogen, and fibrinolytic activity in patients with coronary artery disease Prostaglandins Leukot Essent Fatty Acids, 58: 257-263. (Pubitemid 28275895)
10. Chang MW and Johnson MA (1980). Effect of garlic on carbohydrate metabolism and lipid synthesis in rats. J. Nutr., 110: 931-936. (Pubitemid 10046115)
11. Defronzo RA (1997). Pathogenesis of diabetes. Diabetes, Rev., 5: 177.
12. Desai HG, Kalro RH and Choksi AP (1990). Effect of ginger and garlic on DNA content of gastric aspirate. Indian J. Med., 92: 139-141. (Pubitemid 20300398)
13. Devaki T, Venmahdi S and Govindaraju P (1992). Alterations in protein metabolism in ethanol-ingested rats treated with garlic. Med. Sci. Res., 20: 725-727.
14. Duncan MG (1999). The effects of nutritional supplements on the treatment of depression, diabetes, and hypercholesterolemia in the renal patient. J. Ren. Nutr., 9: 58-62.
15. Eidi A, Eidi M and Esmaeili E (2006). Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats. Phytomedicine, 13: 624-629. (Pubitemid 44666394)
16. Esposito K, Bellastella G and Giugliano D (2011). When metformin fails in Type 2 diabetes mellitus. Arch. Intern. Med., 171(4): 365-366.
17. Fujita H, Yamagami T and Ohshima K (2001). Long-term ingestion of a fermented soybean-derived Touchiextract with alpha-glucosidase inhibitory activity is safe and effective in humans with borderline and mild type- 2 diabetes. J. Nutr., 131: 2105-2108. (Pubitemid 32720638)
18. Golay A (2008). Metformin and body weight. Int. J. Obes., 32: 61-72.
19. Jabbar A, Argani H, Ghorbanihaghjo A and Mahdavi R (2005). Comparison between swallowing and chewing of Garlic on levels of serum lipids, cycloserine, creatinine and lipid peroxidation in renal transplant recipients. Lipids Health Dis., 4: 11.
20. Jain AK Jain AK, Vargar R, Gotzkowsky S and McMahon FG (1993). Can garlic reduce levels of serum lipids? A controlled clinical study. Am. J. Med., 94: 632-635. (Pubitemid 23166711)
21. Jain RC and Vyas CR (1975). Garlic in alloxan-induced diabetic rabbit. Am. J. Clin. Nutr., 28: 684-685.
22. Jain RC and Vyas CR (1974). Hypoglycemic action of onion on rabbits. Br. Med. J., 2: 730.
23. Jain RC and Vyas CR (1973). Hypoglycemic action of onion and garlic. Lancet, 2: 1491.
24. Jelodar GA, Maleki M, Motadayen MH and Sirus S (2005). Effect of fenugreek, onion and garlic on blood glucose and histopathology of pancreas of alloxan induced diabetic rats. Indian J. Med. Sci., 59(2): 64-69. (Pubitemid 40975979)
25. Kannar D, Wattanapenpaiboon N, Savige GS and Wahlqvist ML (2001). Hypocholesterolemic effect of an enteric coated garlic supplement. J. Am. Coll. Nutr., 20: 225-231. (Pubitemid 32606169)
26. Kasuga S, Ushijima M, Morihara N, Itakura Y and Nakata Y (1999). Effect of aged garlic extract (AGE) on hyperglycemia induced by immobilization stress in mice. Nippon Yakurigaku Zassh., 114: 191-197. (Pubitemid 29436719)
27. Kiesewetter H, Jung F, Pindur G, Jung EM, Mrowietz C and Wenzel E (1991). Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int. J. Clin. Pharmacol. Ther. Toxicol., 29: 151-155.
28. King H, Aubert RE and Herman WH (1998). Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care, 21: 1414- 1431.
29. Lee YM, Gweon OC, Seo YJ, Im J, Kang MJ, Kim MJ, Kim JI (2009). Antioxidant effect of garlic and aged black garlic in animal model of type 2 diabetes mellitus. Nutr Res Pract., 3:156-61.
30. Liu CT, Hse H, Lii CK, Chen PS and Sheen LY (2005). Effects of garlic oil and diallyl trisulfide on glycemic control in diabetic rats. Eur. J. Pharmacol., 516: 165- 173.
31. Liu CT, Wong PL, Lii CK, Hse H and Sheen LY (2006). Antidiabetic effect of garlic oil but not diallyl disulfide in rats with streptozotocin-induced diabetes. Food Chem. Toxicol., 44: 1377-1384.
32. Li G, Shi Z, Jia H, Ju J, Wang X, Xia Z, Qin L, Ge C, Xu Y, Cheng L, Chen P and Yuan GA (2000). Clinical investigation on garlicin injection for treatment of unstable angina pectoris and its actions on plasma endothelin and blood sugar levels. J. Tradit. Chin. Med., 20(4): 243-246.
33. Mahmoodi M, Islami MR, Asadi Karam GR, Khaksari M, Sahebghadam Lotfi A, Hajizadeh MR and Mirzaee MR (2006). Study of the effects of raw garlic consumption on the level of lipids and other blood biochemical factors in hyperlipidemic individuals. Pak. J. Pharm. Sci., 19(4): 295-298.
34. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R and Zinman B (2009). Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 32: 193-203.
35. Park SA, Choi MS, Jung UJ, Kim MJ, Kim DJ, Park HM, Park YB and Lee MK (2006). Eucommia ulmoides Oliver leaf extract increases endogenous antioxidant activity in type 2 diabetic mice. J. Med. Food, 9: 474- 479.
36. Peleg A, Hershcocivi T, Lipa R, Anbar R, Redler M and Beigel Y (2003). Effect of Garlic on lipid profile and psychopathologic parameters in people with mildtomoderate hypercholesterolemia. Isr. Med. Assoc. J., 5(9): 637-640. (Pubitemid 37203532)
37. Queiroz YS, Ishimoto EY, Bastos DH, Sampaio GR and Torres EA (2009). Garlic (Allium sativum L.) and ready-to-eat garlic products: In vitro antioxidant activity. Food Chem., 115: 371-374.
38. Scarpello JHB and Howlett HC (2008). Metformin therapy and clinical uses. Diabetes Vasc. Dis. Res., 5: 157-167.
39. Schramm TK, Gislason GH, Vaag A, Rasmussen JN, Folke F, Hansen ML, Fosbøl EL, Køber L, Norgaard ML, Madsen M, Hansen PR and Torp-Pedersen C (2011). Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur. Heart J., epub 6 April 2001, doi:10.1093/ eurheartj/ehr077
40. Siegel G, Walter A, Engel S, Walper A and Michel F (1999). Pleiotropic effects of Garlic. Wien. Med. Wochenschr., 149: 217-224. (Pubitemid 29399811)
41. Siegers CP (1992). Allium sativum. In: Adverse effects of herbal drugs (DeSmet PAGM, Keller K, Hansell R and Chandler R F eds). Springer-Verlag. Berlin, Germany, pp.73-77.
42. Sheela CG and Augusti KT (1992). Anti-diabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium Sativum L. Indian J. Exp. Biol., 30: 523-526.
43. Sheela CG, Kumud K and Augusti KT (1995). Antidiabetic effect of onion and garlic sulfoxide amino acids in rats. Planta Medica., 61: 356-357.
44. Sheela CG and Augusti KT (1992). Anti-diabetic effects of S-allyl cysteine sulphoxide isolated from garlic Allium sativum Linn. Indian J. Exp. Biol., 30: 523-526.
45. Shera AS, Jawad F and Maqsood A (2007). Prevalence of diabetes in Pakistan. Diabetes Res Clin Pr., 76: 219- 222.
46. Sobenin IA, Nedosugova LV, Filatova LV, Balabolkin M I, Gorchakova T V and Alexander N. Orekhov (2008). Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study. Acta Diabetol., 45:1-6.
47. Steiner M and Li W (2001). Recent advances on the nutritional effects associated with use of garlic as a supplement. Aged garlic extract, a modulator of cardiovascular risk factors. A dose finding study on the effects of AGE on platelet functions. J. Nutr., 131: 980S-984S.
48. Steiner M, Khan AH, Holbert D and Lin RI (1996). A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am. J. Clin. Nutr., 64: 866-870.
49. Tanamai J, Veeramanomai S and Indrakosas N (2004). The efficacy of cholesterol-lowering action and side effects of garlic enteric coated tablets in man. J. Med. Assoc. Thai., 87(10): 1156-1161. (Pubitemid 39486771)
50. Tohidi M and Rahbani M (2000). Evaluation of the effects of garlic powder on blood pressure, serum lipids and lipoproteins. Pharmacy journal of Tabriz Univ Med. Sci., 4: 16-20.
51. Turner B, Molgaard C and Markmann P (2004). Effect of Garlic (Allium Sativum) powder tablet on serum lipid, blood pressure and arterial stiffness in normolipidemic volunteers: A randomized double blind, placebo controlled trial. Br. J. Nutr., 92: 701-706.
52. Venmahdi S and Devaki T (1992). Studies on some liver enzymes in rats ingesting ethanol and treated with garlic oil. Med. Sci. Res., 20: 729-731.
53. Wright AD, Cull CA, Macleod KM and Holman RR (2006). Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulphonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73. J Diabetes Complications., 20: 395-401. (Pubitemid 44740219)
54. Youn JY, Park HY and Cho KH (2004). Antihyperglycemic activity of Commelina communis L. inhibition of α-glucosidase. Diabetes Res. Clin. Pract., 66S: S149-S155.
55. Zhang Xh, Lowe D, Giles P, Fell S, Connock MJ and Maslin DJ (2001). Gender may affect the action of garlic oil on plasma cholesterol and glucose levels of normal subjects. J. Nutr., 131: 1471-1478.
56. Zimmet P, Alberti KG and Shaw J (2001). Global and societal implications of the diabetes epidemic. Nature, 414: 782-787. (Pubitemid 34000780)